Nielsen BioSciences
Phase 3The only FDA-approved delayed-type hypersensitivity (DTH) Candida albicans extract-based skin test antigen available to assess cell-mediated immunity.
Founded
2003
Focus
BiologicsDiagnostics
About
The only FDA-approved delayed-type hypersensitivity (DTH) Candida albicans extract-based skin test antigen available to assess cell-mediated immunity.
Company Info
TypePrivate
Founded2003
LocationSan Diego, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile